10th Tumor Models For Combination Targeted Oncology Summit

Paid

From Leveraging Emerging Predictive Technologies to Engineering a Human-Physiologically Relevant Models – Deepen Our Understanding of Tumor Biology, Resistance Mechanisms & Dosing Strategy Following the success of KRAS, HER2, BCMA, drug developers have seen a new wave of novel, combination targeted oncology surging through pipeline.

12-14 July 2022

Healthcare

Discovery On Target 2022

Paid

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. We aim to meet your research needs.

17-20 October 2022

Healthcare

AI/ML-Enabled Drug Discovery – Part 1

Paid

Cambridge Healthtech Institute’s two-part conference on Artificial Intelligence (AI)/Machine Learning (ML)-Enabled Drug Discovery will highlight the increasing use of computational tools, AI modeling, algorithms, and data science for identifying novel drug targets, drug design, virtual screening, lead optimization, and ADME/toxicology assessments.

26-27 September 2023

Healthcare